object
explor
correl
postsever
acut
respiratori
symptom
sar
patient
osteonecrosi
investig
etiolog
postsar
osteonecrosi
select
sensit
molecular
symbol
earli
diagnosi
distinguish
highrisk
popul
method
studi
subject
divid
two
group
sixtytwo
postsar
patient
osteonecrosi
one
group
ageand
sexmatch
healthi
peopl
normal
control
group
empti
stomach
blood
sampl
cubit
vein
collect
group
plasminogen
activ
inhibitor
pai
mean
enzymelink
immunosorb
assay
polymorph
detect
polymeras
chain
reaction
solid
phase
oligonucleotid
assay
result
blood
agent
postsar
patient
chang
obvious
uml
control
group
uml
genotyp
polymorph
detect
postsar
group
control
group
statist
signific
plasma
pai
activ
relat
homozygot
genotyp
reveal
homozygot
genotyp
may
suscept
gene
mark
chines
osteonecrosi
patient
conclus
plasminogen
activ
sensit
blood
symbol
screen
highrisk
suscept
popul
genotyp
may
etiolog
factor
osteonecrosi
osteonecrosi
condit
categor
traumat
nontraumat
nontraumat
may
associ
excess
corticosteroid
administr
alcohol
abus
hematolog
abnorm
character
young
onset
age
year
multipl
joint
involv
among
sever
pathogenes
nontraumat
intravascular
coagul
activ
variou
potenti
risk
factor
may
common
way
result
intraoss
thrombosi
moreov
report
number
public
associ
individu
hypercoagulablehypofibrinolyt
statu
plasminogen
activ
inhibitor
pai
correspond
gene
polymorph
play
import
role
arteri
venou
thrombosi
spring
sever
acut
respiratori
syndrom
sar
virusinduc
diseas
preval
beij
capit
citi
china
comprehens
investig
osteoarticular
complic
experienc
patient
recov
diseas
estim
approxim
percent
patient
may
suffer
multipl
articular
andor
diaphys
necros
remaind
approxim
infect
type
pathogen
treat
corticosteroid
regimen
free
complic
previou
studi
reveal
hypercoagul
hypofibrinolysi
found
patient
postsar
present
studi
pai
correspond
gene
polymorph
determin
order
address
potenti
associ
occurr
thu
provid
theoret
basi
earli
identif
intervent
specif
clinic
data
juli
februari
radiolog
investig
perform
patient
suffer
sar
spring
includ
comprehens
evalu
system
joint
bilater
hip
knee
ankl
shoulder
wrist
patient
use
magnet
reson
imag
mri
comput
tomographi
ct
radiographi
film
evalu
qualifi
radiologist
orthopedist
respect
agreement
final
diagnosi
may
obtain
cooper
discuss
film
result
discrep
opinion
two
independ
profession
total
patient
identifi
men
women
age
year
year
includ
studi
popul
present
studi
follow
baselin
paramet
obtain
patient
mean
receiv
corticosteroid
mg
mg
mean
daili
maxim
dosag
corticosteroid
mg
mg
mean
durat
corticosteroid
medic
day
day
mean
durat
puls
therapi
corticosteroid
mgday
day
day
joint
involv
includ
femor
head
n
hip
unilater
bilater
knee
n
knee
unilater
bilater
shoulder
n
shoulder
unilater
bilater
wrist
n
wrist
unilater
bilater
individu
bone
involv
scaphoid
bone
capit
bone
lunar
bone
shaft
involv
alon
seen
one
patient
total
healthi
volunt
without
sar
steroid
therapi
men
women
age
year
year
includ
present
studi
control
aliquot
fast
blood
sampl
mlper
patient
collect
cubit
vein
diagnosi
month
stop
corticosteroid
therapi
dispens
vacuum
tube
ml
contain
sodium
citrat
solut
edtabas
tube
ml
anticoagulantwhol
blood
ratio
v
v
blood
sampl
anticoagul
tube
gentli
mix
well
centrifug
rpm
room
temperatur
min
collect
supernat
plasma
plasma
plasminogen
activ
inhibitor
pai
determin
use
elisa
without
necess
perform
dilut
plasma
sampl
calibr
curv
examin
start
point
calibr
owrenkol
buffer
qualiti
control
establish
determin
paramet
test
read
collect
nm
vwf
nm
dd
nm
procedur
determin
perform
automat
ninehundr
microlit
stmt
dilut
steril
doubl
distil
water
ratio
v
v
ad
edtaanticoagul
whole
blood
gentli
mix
well
stood
ice
min
centrifug
rpm
remov
supernat
ad
guanidinium
isothiocyan
n
result
white
precipit
gentli
shaken
ad
rnase
stood
room
temperatur
min
product
ad
n
naclo
ph
resin
mix
suffici
immedi
use
stood
room
temperatur
min
centrifug
rpm
remov
supernat
precipit
ad
wash
buffer
centrifug
rpm
remov
supernat
procedur
perform
twice
product
centrifug
rpm
pipet
remain
liquid
stood
room
temperatur
min
ad
te
buffer
incub
min
centrifug
rpm
remov
supernat
result
precipit
dna
amplif
hybrid
label
determin
gene
amplif
hybrid
label
determin
gene
perform
use
pcr
solid
phase
oligonucleotid
assay
spola
eleven
microlit
pcr
mix
contain
amplimix
primer
h
sampl
dna
syber
green
neg
control
h
ad
lightcycl
capillari
use
transferpettor
place
roch
pcr
disc
procedur
establish
lightcycl
experi
follow
cycl
product
store
test
sampl
capillari
subject
centrifug
ad
hybrid
solut
contain
probe
buffer
h
mutat
control
normal
control
respect
mix
well
solut
insid
capillari
transfer
wt
well
mut
well
plate
incub
room
temperatur
min
one
hundr
microlit
label
solut
contain
ligas
buffer
h
ad
well
incub
room
temperatur
min
solut
well
remov
wash
buffer
ad
remov
soon
wash
procedur
perform
product
well
ad
specif
enzymeconjug
antibodi
incub
room
temperatur
min
wash
twice
ad
substrat
incub
room
temperatur
min
ad
stop
buffer
determin
sampl
measur
od
valu
nm
micropl
reader
base
equat
r
od
wt
od
mut
normal
control
calibr
defin
r
c
mutat
control
r
b
result
defin
follow
base
magnitud
r
r
c
r
b
b
r
b
data
repres
mean
sd
test
statist
signific
use
softwar
packag
view
nonnorm
major
data
differ
postsar
group
control
group
evalu
use
wilcoxon
nonparametr
test
differ
pai
genotyp
correspond
pai
valu
two
group
analyz
use
anova
p
valu
consid
statist
signific
patient
postsar
pai
valu
uml
exhibit
signific
hypofibrinolyt
tendenc
control
group
uml
genotyp
patient
frequent
see
control
group
without
statist
signific
patient
increas
genotyp
also
prone
increas
plasma
pai
indic
potenti
correl
pai
gene
plasma
activ
detail
tabl
pai
valu
rel
differ
genotyp
control
group
show
signific
differ
fig
recent
year
associ
disord
coagul
fibrinolysi
system
becom
increasingli
highlight
demonstr
numer
studi
nontraumat
close
relat
coagul
fibrinolysi
disord
intravascular
coagulationinduc
thrombosi
subchondr
microcircul
may
result
intraoss
hypertens
reduc
blood
stream
osteocyt
ischemiahypoxia
consequ
lead
necrosi
bone
cell
theori
support
studi
conduct
starklint
et
al
found
fibrin
thrombi
area
hypercoagulablehypofibrinolyt
statu
inher
acquir
result
excess
corticosteroid
administr
patient
sar
may
develop
hypercoagulablehypofibrinolyt
statu
attribut
intraoss
thrombosi
result
therapi
corticosteroid
may
provid
recipi
prethrombot
stage
patholog
state
may
contribut
thrombosi
patient
previous
exist
hypercoagulablehypofibrinolyt
statu
corticosteroid
therapi
may
riski
format
call
second
hit
theori
fibrinolysi
system
compris
seri
actor
substrat
activ
inhibitor
particip
convers
plasminogen
activ
fibrinogenas
subsequ
action
fibrin
fibrinolysi
inde
chain
reaction
catalyz
group
protein
mainli
function
immedi
lyze
fibrin
clot
creat
local
tempor
prevent
thrombosi
among
factor
plasminogen
activ
inhibitor
pai
member
serin
proteinas
inhibitor
mainli
take
effect
via
deactiv
tissu
plasminogen
activ
present
increas
activ
hypercoagul
thrombot
diseas
correl
fibrinolyt
disord
confirm
mani
public
similar
studi
glueck
et
al
correl
pai
establish
studi
report
pai
increas
patient
postsar
human
gene
locat
chromosom
contain
exon
intron
recent
studi
reveal
polymorph
may
gener
insert
guanosin
g
bp
upstream
transcript
initi
site
promot
region
seen
clinic
observ
studi
polymorph
may
close
relat
plasma
activ
allel
may
associ
increas
plasma
level
glueck
seri
patient
identifi
homozygot
versu
control
consid
pai
polymorph
may
caus
factor
paolo
et
al
perform
determin
gene
patient
develop
posterior
renal
transplant
reveal
presenc
frequent
see
patient
group
patient
absent
thu
conclud
genotyp
serv
indictor
posterior
renal
transplant
moreov
report
asano
et
al
discrep
race
may
observ
aspect
sinc
correl
found
gene
polymorph
japanes
postren
transplant
found
present
studi
allel
frequent
see
patient
postsar
without
signific
differ
possibl
due
limit
small
sampl
size
statist
method
use
present
studi
plasma
pai
level
higher
patient
genotyp
two
genotyp
suggest
correl
increas
pai
level
genotyp
indic
pai
may
potenti
biomark
use
screen
predispos
factor
pai
genotyp
may
genet
marker
chines
patient
conclus
pai
genotyp
deserv
import
valu
screen
popul
highli
suscept
nontraumat
osteonecrosi
p
p
comparison
two
pai
valu
rel
genotyp
patient
